Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Toby Trujillo to Anticoagulants

This is a "connection" page, showing publications Toby Trujillo has written about Anticoagulants.

 
Connection Strength
 
 
 
3.463
 
  1. Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy. 2020 11; 40(11):1130-1151.
    View in: PubMed
    Score: 0.503
  2. Trujillo TC, Dobesh PP, Crossley GH, Finks SW. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation. Pharmacotherapy. 2019 01; 39(1):94-108.
    View in: PubMed
    Score: 0.444
  3. Trujillo T, Dobesh PP. Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications. Drugs. 2014 Sep; 74(14):1587-603.
    View in: PubMed
    Score: 0.328
  4. Burnett AE, Trujillo TC. The future of inpatient anticoagulation management. J Thromb Thrombolysis. 2013 Apr; 35(3):375-86.
    View in: PubMed
    Score: 0.297
  5. Dobesh PP, Trujillo TC. Anticoagulation in the management of ST-segment elevation myocardial infarction. J Pharm Pract. 2010 Aug; 23(4):335-43.
    View in: PubMed
    Score: 0.244
  6. Trujillo TC. Emerging anticoagulants for venous thromboembolism prevention. Am J Health Syst Pharm. 2010 May 15; 67(10 Suppl 6):S17-25.
    View in: PubMed
    Score: 0.244
  7. Haines ST, Dager WE, Trujillo TC. Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion. Am J Health Syst Pharm. 2010 May 15; 67(10 Suppl 6):S26-30.
    View in: PubMed
    Score: 0.244
  8. Dobesh PP, Trujillo TC. Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome. J Pharm Pract. 2010 Aug; 23(4):324-34.
    View in: PubMed
    Score: 0.243
  9. Beavers CJ, DiDomenico RJ, Dunn SP, Cox J, To L, Weeks P, Trujillo TC, Jennings DL. Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy. 2021 11; 41(11):932-942.
    View in: PubMed
    Score: 0.135
  10. Farrar JE, Trujillo TC, Mueller SW, Beltran L, Nguyen C, Hassell K, Kiser TH. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19. J Thromb Thrombolysis. 2022 Feb; 53(2):446-453.
    View in: PubMed
    Score: 0.133
  11. Finks SW, Dobesh PP, Trujillo TC, Crossley GH. Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures. Cardiol Rev. 2018 Sep/Oct; 26(5):245-254.
    View in: PubMed
    Score: 0.108
  12. Smythe MA, Trujillo T, Fanikos J. Reversal agents for use with direct and indirect anticoagulants. Am J Health Syst Pharm. 2016 May 15; 73(10 Suppl 2):S27-48.
    View in: PubMed
    Score: 0.092
  13. Finks SW, Trujillo TC, Dobesh PP. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. Ann Pharmacother. 2016 06; 50(6):486-501.
    View in: PubMed
    Score: 0.091
  14. Anderson M, Hassell KL, Trujillo TC, Wolfe B. When patients on target-specific oral anticoagulants need surgery. Cleve Clin J Med. 2014 Oct; 81(10):629-39.
    View in: PubMed
    Score: 0.082
  15. Miller MP, Trujillo TC, Nordenholz KE. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants. Am J Emerg Med. 2014 Apr; 32(4):375-82.
    View in: PubMed
    Score: 0.078
  16. Dager WE, Trujillo TC, Gilbert BW. Approaches to Precision-based Anticoagulation management in the critically Ill. Pharmacotherapy. 2023 Nov; 43(11):1221-1236.
    View in: PubMed
    Score: 0.038
  17. Novak AR, Shakowski C, Trujillo TC, Wright GC, Mueller SW, Kiser TH. Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism. J Thromb Thrombolysis. 2022 Aug; 54(2):276-286.
    View in: PubMed
    Score: 0.035
  18. Courtney LA, Trujillo TC, Saseen JJ, Wright G, Palkimas S. Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge. Ann Pharmacother. 2022 09; 56(9):981-987.
    View in: PubMed
    Score: 0.034
  19. Williams B, Saseen JJ, Trujillo T, Palkimas S. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome. J Thromb Thrombolysis. 2022 Jul; 54(1):67-73.
    View in: PubMed
    Score: 0.034
  20. Beyer J, Trujillo T, Fisher S, Ko A, Lind SE, Kiser TH. Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors. Clin Appl Thromb Hemost. 2016 Jul; 22(5):423-8.
    View in: PubMed
    Score: 0.023
  21. Dobesh PP, Trujillo TC, Finks SW. Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism. Pharmacotherapy. 2013 Jun; 33(6):650-64.
    View in: PubMed
    Score: 0.019
  22. Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Trujillo TC, Gulseth MP, Nutescu E, Vondracek T. Key articles and guidelines in the treatment of venous thromboembolism. Pharmacotherapy. 2009 Nov; 29(11):1385.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)